Focus Partners Wealth
LAB icon

Focus Partners Wealth’s Standard BioTools LAB Stock Holding History

Focus Partners Wealth’s Portfolio LAB Stock Details LAB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$22.3K Buy
24,225
+9,582
+65% +$11.6K ﹤0.01% 2608
2025
Q4 		$18.7K Sell
14,643
-392
-3% -$527 ﹤0.01% 2629
2025
Q3 		$19.5K Sell
15,035
-92
-0.6% -$121 ﹤0.01% 2187
2025
Q2 		$18.2K Sell
15,127
-155
-1% -$172 ﹤0.01% 2007
2025
Q1 		$16.5K Buy
15,282
+1,227
+9% +$1.72K ﹤0.01% 1876
2024
Q4 		$24.6K Buy
14,055
+1,053
+8% +$1.96K ﹤0.01% 1845
2024
Q3 		$25.1K Buy
+13,002
New +$25.5K ﹤0.01% 1553

Other funds holding LAB

CC
Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
MCO
MAK Capital One New York $679M AUM 29.02% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
LFCM
Long Focus Capital Management San Juan, Puerto Rico $3.8B AUM 7.31% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
HBWM
Hollow Brook Wealth Management Katonah, New York $392M AUM 36.68% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return

Focus Partners Wealth's LAB Position: Q1 2026 in Review

Focus Partners Wealth increased its Standard BioTools (LAB) stake by 65% in Q1 2026, buying an estimated $11.6K and bringing the position to 24,225 shares worth $22.3K. The position accounts for ﹤0.01% of the portfolio, ranked #2608.

Focus Partners Wealth first reported a position in LAB in Q3 2024 and has held it in 7 quarters since. The position peaked at $25.1K in Q3 2024. 155 funds tracked by Wall St. Rank hold LAB as of Q1 2026.

  • Focus Partners Wealth held 24,225 shares of Standard BioTools worth $22.3K as of Q1 2026.
  • Focus Partners Wealth bought 9,582 Standard BioTools shares in Q1 2026, an estimated $11.6K.
  • Standard BioTools made up ﹤0.01% of Focus Partners Wealth's portfolio in Q1 2026, its #2608 holding.
  • Focus Partners Wealth first reported a position in Standard BioTools in Q3 2024 and has held it in 7 quarters since.
  • Focus Partners Wealth's Standard BioTools position peaked at $25.1K in Q3 2024.
  • 155 funds tracked by Wall St. Rank held Standard BioTools as of Q1 2026.

Based on Focus Partners Wealth's 13F filing for Q1 2026, filed 15 May 2026.